跳至主要内容
临床试验/NCT00940576
NCT00940576已完成不适用

Dietetic Effects of Mare's Milk in Patients With Chronic Inflammatory Bowel Diseases (IBD) - a Double Blind Placebo Controlled Cross-over Study.

University of Jena4 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2000年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
17
试验地点
4
主要终点
Score of Crohn´s Disease and/or Ulcerative Colitis

研究概览

简要总结

Mare's milk consumption could improve the well-being in patients with Crohn's disease and ulcerative colitis, respectively.

详细描述

Background: Dietetic effects of mare's milk have been reported for a long time and can be based on bactericidal and immunological components of mare's milk.

Objective

Dietetic effects of oral intake of mare's milk in adolescent patients with chronic inflammatory bowel diseases were investigated.

Design: In a randomized, placebo-controlled, double-blind, cross-over intervention study, eight Crohn's disease patients and nine ulcerative colitis patients received daily 250 mL mare's milk or placebo drink.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • clear and definite diagnosis of ulcerative colitis and Crohn's disease resp.

排除标准

  • lactose intolerance and pregnancy

结局指标

主要结局

Score of Crohn´s Disease and/or Ulcerative Colitis

时间窗: 8 weeks

score for Crohn´s disease: Crohn´s Disease Activity Index (CDAI), \< 150 = remission, 151-220 = moderate activity, 221-450 = severe activity; score for ulcerative colitis: Colitis Activity Index (CAI), 0-4 = remission, 5-9 = low activity, 10-16 = moderate activity, 17-23 = high activity.

次要结局

  • Extra-intestinal Pain(8 weeks)

研究者

发起方
University of Jena
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gerhard Jahreis

Prof. Dr.

University of Jena

研究点 (4)

Loading locations...

相似试验

Dietetic Efficacy of Mare's Milk for Patients With... | 临床试验